NMPA Announcement on Issues Pertaining to Online Application for Drug Registration Affairs
Release time：2021-12-12
NMPA Announcement on Issues Pertaining to Online Application for Drug Registration Affairs
As per the requirements of the Notice of the General Office of the
State Council on the Issuance of Implementation Program for Furtherance
of the 'Internet + Government Affairs Service' and the 'One Network, One
Door, One Time (One Network Online Service, One Door Offline Service
and One Time On-Site Service)' Reform and the Guiding Opinions of the
General Office of the State Council on Accelerating 'Crossprovincial
Handling' of Government Affairs Services, the NMPA has enabled and
officially launched on January 1, 2021 the online application module for
drug registration affairs. Applicants for drug registration shall
complete user registration and authorizationbased binding of the drug
business application system through the Online Service Hall of the NMPA
(http://zwfw.nmpa.gov.cn/) as per the Operation Guidelines for
Enterprises on harmaceutical Related Application System. As of January
1, 2021, drug registration can be applied online. For the smooth and
steady transition of drug registration, relevant drug registration
applicants can continue to use the original drug registration
application software to fill in the application after the Online
Application Module is launched. As of April 1, 2021, application offers
generated by the original drug registration application software shall
no longer be handled.
Reprint statement: reprint please indicate "source: Wista pharma".
86-10-67887855
Head Office：5F, Building No.6, HAN's Enterprise Bay, Liangshuihe No.2 Street, Beijing Economic Technological Development Area, Beijing, 100176, P.R.China
Marketing：sales@51cns.com
Wista Pharmam
简体中文
